MGI GP (GLFD) 8-K Financial statements and exhibits

Written Statement of Chief Executive Officer and Chief Financial Officer
Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

     The undersigned, the Chief Executive Officer and the Chief Financial Officer of Guilford Pharmaceuticals Inc. (the “Company”), each hereby certifies that, to his/her knowledge on the date hereof:

(a)	the Form 10-Q of the Company for the Quarterly Period Ended June 30, 2002 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b)	information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Craig R. Smith, M.D.
Craig R. Smith, M.D.
Chairman of the Board and
Chief Executive Officer
August 14, 2002

/s/ Andrew R. Jordan
Andrew R. Jordan
Senior Vice President and
Chief Financial Officer
August 14, 2002